A detailed history of Private Advisor Group, LLC transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 34,325 shares of IMMX stock, worth $54,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,325
Previous 65,175 47.33%
Holding current value
$54,576
Previous $129,000 60.47%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$1.49 - $2.45 $45,966 - $75,582
-30,850 Reduced 47.33%
34,325 $51,000
Q2 2024

Aug 05, 2024

SELL
$1.81 - $3.06 $60,816 - $102,816
-33,600 Reduced 34.02%
65,175 $129,000
Q1 2024

Apr 30, 2024

SELL
$2.64 - $6.68 $2,640 - $6,680
-1,000 Reduced 1.0%
98,775 $303,000
Q4 2023

Feb 06, 2024

BUY
$2.82 - $7.27 $281,365 - $725,364
99,775 New
99,775 $690,000

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $22.1M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.